A drug shortage is a quality failure with a body count.
Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.
By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.
The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.
| Drug | Company | Therapeutic area | Availability | Status | Posted |
|---|---|---|---|---|---|
| Amino Acid InjectionInjection | Baxter Healthcare | Gastroenterology | Available | Current | 2020-12-08 |
| Ifosfamide InjectionInjection | Baxter Healthcare | Oncology | Unavailable | Current | 2026-06-12 |
| Clindamycin Phosphate InjectionInjection | Baxter Healthcare | Anti-Infective | Limited | Current | 2023-03-21 |
| Dextrose Monohydrate 70% InjectionInjection | Baxter Healthcare | Endocrinology/Metabolism | Limited | Current | 2024-10-11 |
| Ketorolac Tromethamine InjectionInjection | Baxter Healthcare | Analgesia/Addiction | Unavailable | Current | 2018-06-06 |
| Dexmedetomidine Hydrochloride InjectionInjection | Baxter Healthcare | Anesthesia | Available | Current | 2020-04-10 |
| Dextrose Monohydrate 10% InjectionInjection | Baxter Healthcare | Endocrinology/Metabolism | Available | Current | 2022-03-01 |
| Dexmedetomidine Hydrochloride InjectionInjection | Baxter Healthcare | Anesthesia | Limited | Current | 2020-04-10 |
| Dopamine Hydrochloride InjectionInjection | Baxter Healthcare | Cardiovascular | Available | Current | 2017-11-06 |
| Carboplatin InjectionInjection | Accord Healthcare Inc. | Oncology | Unavailable | Current | 2023-04-28 |
| Furosemide InjectionInjection | Accord Healthcare Inc. | Cardiovascular | Unavailable | Current | 2020-04-07 |
| Sodium Acetate InjectionInjection | Milla Pharmaceuticals | Total Parenteral Nutrition | Available | Current | 2016-03-23 |
| Quinapril Hydrochloride TabletTablet | Lupin Pharmaceuticals, Inc. | Cardiovascular | Unavailable | Current | 2023-01-19 |
| Rifampin CapsuleCapsule | Lupin Pharmaceuticals, Inc. | Anti-Infective | Limited | Current | 2021-12-22 |
| Cromolyn Sodium ConcentrateConcentrate | Ailex Pharmaceuticals | Pulmonary/Allergy | Available | Current | 2023-11-03 |
| Sodium Acetate InjectionInjection | Milla Pharmaceuticals | Total Parenteral Nutrition | Available | Current | 2016-03-23 |
| Tobramycin Sulfate InjectionInjection | Hospira, Inc., a Pfizer Company | Anti-Infective | — | To Be Discontinued | 2026-07-17 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Mylan Pharmaceuticals Inc., a Viatris Company | Psychiatry | Available | Current | 2023-07-14 |
| Remifentanil Hydrochloride InjectionInjection | Mylan Institutional, a Viatris Company | Analgesia/Addiction | Available | Current | 2022-06-28 |
| Etomidate InjectionInjection | Mylan Institutional, a Viatris Company | Anesthesia | Available | Current | 2022-10-05 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Mylan Pharmaceuticals Inc., a Viatris Company | Psychiatry | Available | Current | 2023-07-14 |
| Cromolyn Sodium ConcentrateConcentrate | Ailex Pharmaceuticals | Pulmonary/Allergy | Limited | Current | 2023-11-03 |
| Rifampin CapsuleCapsule | Lupin Pharmaceuticals, Inc. | Anti-Infective | Limited | Current | 2021-12-22 |
| Remifentanil Hydrochloride InjectionInjection | Mylan Institutional, a Viatris Company | Analgesia/Addiction | Available | Current | 2022-06-28 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Mylan Pharmaceuticals Inc., a Viatris Company | Psychiatry | Available | Current | 2023-07-14 |
Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).